Alfresa Holdings Corporation (TYO:2784)

Japan flag Japan · Delayed Price · Currency is JPY
2,156.00
+2.00 (0.09%)
Jul 28, 2025, 3:30 PM JST
0.09%
Market Cap391.94B
Revenue (ttm)2.96T
Net Income (ttm)27.39B
Shares Out181.79M
EPS (ttm)147.54
PE Ratio14.61
Forward PE13.08
Dividend68.00 (3.16%)
Ex-Dividend DateSep 29, 2025
Volume302,700
Average Volume371,165
Open2,150.00
Previous Close2,154.00
Day's Range2,146.50 - 2,170.50
52-Week Range1,897.00 - 2,473.50
Beta-0.12
RSI79.52
Earnings DateAug 6, 2025

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements,... [Read more]

Sector Healthcare
Founded 2003
Employees 12,452
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 2784
Full Company Profile

Financial Performance

In 2024, Alfresa Holdings's revenue was 2.96 trillion, an increase of 3.59% compared to the previous year's 2.86 trillion. Earnings were 27.39 billion, a decrease of -7.34%.

Financial Statements

News

There is no news available yet.